부산대학교 도서관

Hasan Alsaid; Shih-Hsun Cheng; Meixia Bi; Fang Xie; Mary Rambo; Tinamarie Skedzielewski; Bao Hoang; Sunish Mohanan; Debra Comroe; Andrew Gehman; Chih-Yang Hsu; Kamyar Farhangi; Hoang Tran; Valeriia Sherina; Minh Doan; M. Reid Groseclose; Christopher B. Hopson; Sara Brett; Ian A. Wilson; Andrew Nicholls; Marc Ballas; Jeremy D. Waight; Beat M. Jucker

Mol Imaging Biol

Hasan Alsaid; Shih-Hsun Cheng; Meixia Bi; Mary V. Rambo; Tinamarie Skedzielewski; Bao Hoang; Sunish Mohanan; Andrew Gehman; Chih-Yang Hsu; Minh Doan; Fang Xie; M. Reid Groseclose; Christopher Hopson; Sara Brett; Ian A. Wilson; Andrew Nicholls; Marc Ballas; Jeremy D. Waight; Beat M. Jucker; Axel Hoos

Cancer Research. 81:2816-2816

Alsaid, Hasan; Cheng, Shih-Hsun; Bi, Meixia; Xie, Fang; Rambo, Mary; Skedzielewski, Tinamarie; Hoang, Bao; Mohanan, Sunish; Comroe, Debra; Gehman, Andrew; Hsu, Chih-Yang; Farhangi, Kamyar; Tran, Hoang; Sherina, Valeriia; Doan, Minh; Groseclose, M. Reid; Hopson, Christopher B.; Brett, Sara; Wilson, Ian A.; Nicholls, Andrew; et al

Molecular Imaging & Biology (MOLECULAR IMAGING BIOL), Jun2023; 25(3): 528-540. (13p)

Saaussan Madi; Fang Xie; Kamyar Farhangi; Chih-Yang Hsu; Shih-Hsun Cheng; Tolulope Aweda; Bhasker Radaram; Stephanie Slania; Tammy Lambert; Mary Rambo; Tina Skedzielewski; Austin Cole; Valeriia Sherina; Shannon McKearnan; Hoang Tran; Hasan Alsaid; Minh Doan; Alan H. Stokes; Derek T. O’Hagan; Giulietta Maruggi; Sylvie Bertholet; Stéphane T. Temmerman; Russell Johnson; Beat M. Jucker

Frontiers in Immunology, Vol 13 (2023)

Groseclose MR; Bioimaging, GSK, Collegeville, PA, USA. reid.x.groseclose@gsk.com.; Barry JA; Bioimaging, GSK, Collegeville, PA, USA.; Skedzielewski T; Bioimaging, GSK, Collegeville, PA, USA.; Pang Y; DMPK, GSK, Collegeville, PA, USA.; Li Y; DMPK, GSK, Collegeville, PA, USA.; McDermott G; Laboratory Animal Sciences and Governance, GSK, Collegeville, PA, USA.; Deutsch J; Laboratory Animal Sciences and Governance, GSK, Collegeville, PA, USA.; Balabhadrapatruni C; Oncology Research Unit, GSK, Collegeville, PA, USA.; Benson W; Bioimaging, GSK, Collegeville, PA, USA.; Lim D; Research Statistics, Biostatistics, GSK, Collegeville, PA, USA.; Tran H; Research Statistics, Biostatistics, GSK, Collegeville, PA, USA.; Minthorn E; DMPK, GSK, Collegeville, PA, USA.; Kmett C; DMPK, GSK, Collegeville, PA, USA.; Roethke T; DMPK, GSK, Collegeville, PA, USA.; Berry S; DMPK, GSK, Collegeville, PA, USA.; McCormick E; DMPK, GSK, Collegeville, PA, USA.; Feeney W; Laboratory Animal Sciences and Governance, GSK, Collegeville, PA, USA.; Ringenberg MA; Nonclinical Safety, GSK, Collegeville, PA, USA.; Maguire S; Laboratory Animal Sciences and Governance, GSK, Collegeville, PA, USA.; Sharma G; Oncology Research Unit, GSK, Collegeville, PA, USA.; Aziez A; Global Medical Affairs Oncology, GSK, Zug, Switzerland.; Paul EM; Oncology Medicine Development, GSK, Collegeville, PA, USA.; Taskar K; DMPK, GSK, Collegeville, PA, USA.; Gada K; DMPK, GSK, Collegeville, PA, USA.; Alsaid H; Bioimaging, GSK, Collegeville, PA, USA.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

Aweda TA; Bioimaging, GSK, 1250 S. Collegeville Rd, Collegeville, PA, 19426, USA.; Cheng SH; Bioimaging, GSK, 1250 S. Collegeville Rd, Collegeville, PA, 19426, USA.; Lenhard SC; Bioimaging, GSK, 1250 S. Collegeville Rd, Collegeville, PA, 19426, USA.; Sepp A; Certara UK Ltd, Sheffield, UK.; Skedzielewski T; Bioimaging, GSK, 1250 S. Collegeville Rd, Collegeville, PA, 19426, USA.; Hsu CY; Bioimaging, GSK, 1250 S. Collegeville Rd, Collegeville, PA, 19426, USA.; Marshall S; Integrated Biological Platform Sciences, GSK, Collegeville, PA, USA.; Haag H; Integrated Biological Platform Sciences, GSK, Collegeville, PA, USA.; Kehler J; Bioanalysis, Immunogenicity & Biomarkers, GSK, Collegeville, PA, USA.; Jagdale P; DMPK, GSK, Collegeville, PA, USA.; Peter A; mAb Engineering & Bioanalytics, Humabs BioMed SA, Vir Biotechnology, Inc, Bellinzona, Switzerland.; Schmid MA; mAb Engineering & Bioanalytics, Humabs BioMed SA, Vir Biotechnology, Inc, Bellinzona, Switzerland.; Gehman A; Non-Clinical and Translational Statistics, GSK, Collegeville, PA, USA.; Doan M; Bioimaging, GSK, 1250 S. Collegeville Rd, Collegeville, PA, 19426, USA.; Mayer AP; Bioanalysis, Immunogenicity & Biomarkers, GSK, Collegeville, PA, USA.; Gorycki P; DMPK, GSK, Collegeville, PA, USA.; Fanget M; Bioanalytical Department, Vir Biotechnology, Inc, San Francisco, CA, USA.; Colas C; DMPK, Vir Biotechnology, Inc, San Francisco, CA, USA.; Smith B; Toxicology, Vir Biotechnology, Inc, San Francisco, CA, USA.; Maier CC; Non-Clinical Safety, GSK, Collegeville, PA, USA.; Alsaid H; Bioimaging, GSK, 1250 S. Collegeville Rd, Collegeville, PA, 19426, USA. hasan.5.alsaid@gsk.com.

Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1619-7089 (Electronic) Linking ISSN: 16197070 NLM ISO Abbreviation: Eur J Nucl Med Mol Imaging Subsets: MEDLINE

Cheng SH; Bioimaging, GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426-2990, USA. Electronic address: shih-hsun.x.cheng@gsk.com.; Groseclose MR; Bioimaging, GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426-2990, USA.; Mininger C; Infectious disease Research Unit, GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426-2990, USA.; Bergstrom M; Clinical imaging, GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426-2990, USA.; Zhang L; Infectious disease Research Unit, GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426-2990, USA.; Lenhard SC; Bioimaging, GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426-2990, USA.; Skedzielewski T; Bioimaging, GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426-2990, USA.; Kelley ZD; Bioimaging, GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426-2990, USA.; Comroe D; In Vivo Science and Delivery, GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426-2990, USA.; Hong H; Bioimaging, GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426-2990, USA.; Cui H; Infectious disease Research Unit, GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426-2990, USA; Jemincare, Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai 201203, China.; Hoover JL; Infectious disease Research Unit, GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426-2990, USA.; Rittenhouse S; Infectious disease Research Unit, GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426-2990, USA.; Castellino S; Bioimaging, GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426-2990, USA; Xenovista LLC, 3622 Travis Ct, Chapel Hill, NC 27516, USA.; Jucker BM; Clinical imaging, GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426-2990, USA.; Alsaid H; Bioimaging, GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426-2990, USA. Electronic address: hasan.5.alsaid@gsk.com.

Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE

Solomon HM; Reproductive Toxicology, Platform Technology and Science, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania.; Murzyn S; Reproductive Toxicology, Platform Technology and Science, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania.; Rendemonti J; Reproductive Toxicology, Platform Technology and Science, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania.; Chapman S; Reproductive Toxicology, Platform Technology and Science, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania.; Skedzielewski T; Bioimaging, Platform Technology and Science, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania.; Jucker BM; Bioimaging, Platform Technology and Science, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania.; Stanislaus D; Reproductive Toxicology, Platform Technology and Science, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania.; Alsaid H; Bioimaging, Platform Technology and Science, GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania.

Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101701004 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2472-1727 (Electronic) NLM ISO Abbreviation: Birth Defects Res Subsets: MEDLINE

Alsaid H; Bioimaging, Platform Technology & Science, GlaxoSmithKline, King of Prussia, Pennsylvania, United States of America.; Skedzielewski T; Bioimaging, Platform Technology & Science, GlaxoSmithKline, King of Prussia, Pennsylvania, United States of America.; Rambo MV; Bioimaging, Platform Technology & Science, GlaxoSmithKline, King of Prussia, Pennsylvania, United States of America.; Hunsinger K; Bioimaging, Platform Technology & Science, GlaxoSmithKline, King of Prussia, Pennsylvania, United States of America.; Hoang B; Target Sciences Target & Pathway, GlaxoSmithKline, King of Prussia, Pennsylvania, United States of America.; Fieles W; Target Sciences Target & Pathway, GlaxoSmithKline, King of Prussia, Pennsylvania, United States of America.; Long ER; Integrated Biological Platform Sciences, Platform Technology & Science, GlaxoSmithKline, King of Prussia, Pennsylvania, United States of America.; Tunstead J; Target Sciences Target & Pathway, GlaxoSmithKline, King of Prussia, Pennsylvania, United States of America.; Vugts DJ; Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands.; Cleveland M; Bioimaging, Platform Technology & Science, GlaxoSmithKline, Stevenage, United Kingdom.; Clarke N; Biopharm Molecular Discovery, GlaxoSmithKline, Stevenage, United Kingdom.; Matheny C; Immunoginicity and Biomarkers, Platform Technology & Science, GlaxoSmithKline, King of Prussia, Pennsylvania, United States of America.; Jucker BM; Bioimaging, Platform Technology & Science, GlaxoSmithKline, King of Prussia, Pennsylvania, United States of America.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

K. E. Linder; E. Metcalfe; P. Nanjappan; T. Arunachalam; T. M. Skedzielewski; K. Ramos; A. D. Nunn; M. F. Tweedle; R. E. Swenson

Contrast Media & Molecular Imaging. 4:265-265

Lenhard SC; Bioimaging (S.C.L., T.S., M.R., S.-H.C., H.H., B.M.J.), Renal Discovery Group, Future Pipeline Discovery (A.V, E.H.), Experimental Cell and Tissue Biology, Target and Pathway Validation (W.F., H.T., R.G., J.-L.K.), Drug Delivery (A.M., D.L.), and Drug Design and Selection (A.I.-L., A.N.), GlaxoSmithKline plc, Collegeville, Pennsylvania.; McAlexander A; Bioimaging (S.C.L., T.S., M.R., S.-H.C., H.H., B.M.J.), Renal Discovery Group, Future Pipeline Discovery (A.V, E.H.), Experimental Cell and Tissue Biology, Target and Pathway Validation (W.F., H.T., R.G., J.-L.K.), Drug Delivery (A.M., D.L.), and Drug Design and Selection (A.I.-L., A.N.), GlaxoSmithKline plc, Collegeville, Pennsylvania.; Virtue A; Bioimaging (S.C.L., T.S., M.R., S.-H.C., H.H., B.M.J.), Renal Discovery Group, Future Pipeline Discovery (A.V, E.H.), Experimental Cell and Tissue Biology, Target and Pathway Validation (W.F., H.T., R.G., J.-L.K.), Drug Delivery (A.M., D.L.), and Drug Design and Selection (A.I.-L., A.N.), GlaxoSmithKline plc, Collegeville, Pennsylvania.; Fieles W; Bioimaging (S.C.L., T.S., M.R., S.-H.C., H.H., B.M.J.), Renal Discovery Group, Future Pipeline Discovery (A.V, E.H.), Experimental Cell and Tissue Biology, Target and Pathway Validation (W.F., H.T., R.G., J.-L.K.), Drug Delivery (A.M., D.L.), and Drug Design and Selection (A.I.-L., A.N.), GlaxoSmithKline plc, Collegeville, Pennsylvania.; Skedzielewski T; Bioimaging (S.C.L., T.S., M.R., S.-H.C., H.H., B.M.J.), Renal Discovery Group, Future Pipeline Discovery (A.V, E.H.), Experimental Cell and Tissue Biology, Target and Pathway Validation (W.F., H.T., R.G., J.-L.K.), Drug Delivery (A.M., D.L.), and Drug Design and Selection (A.I.-L., A.N.), GlaxoSmithKline plc, Collegeville, Pennsylvania.; Rambo M; Bioimaging (S.C.L., T.S., M.R., S.-H.C., H.H., B.M.J.), Renal Discovery Group, Future Pipeline Discovery (A.V, E.H.), Experimental Cell and Tissue Biology, Target and Pathway Validation (W.F., H.T., R.G., J.-L.K.), Drug Delivery (A.M., D.L.), and Drug Design and Selection (A.I.-L., A.N.), GlaxoSmithKline plc, Collegeville, Pennsylvania.; Trinh H; Bioimaging (S.C.L., T.S., M.R., S.-H.C., H.H., B.M.J.), Renal Discovery Group, Future Pipeline Discovery (A.V, E.H.), Experimental Cell and Tissue Biology, Target and Pathway Validation (W.F., H.T., R.G., J.-L.K.), Drug Delivery (A.M., D.L.), and Drug Design and Selection (A.I.-L., A.N.), GlaxoSmithKline plc, Collegeville, Pennsylvania.; Cheng SH; Bioimaging (S.C.L., T.S., M.R., S.-H.C., H.H., B.M.J.), Renal Discovery Group, Future Pipeline Discovery (A.V, E.H.), Experimental Cell and Tissue Biology, Target and Pathway Validation (W.F., H.T., R.G., J.-L.K.), Drug Delivery (A.M., D.L.), and Drug Design and Selection (A.I.-L., A.N.), GlaxoSmithKline plc, Collegeville, Pennsylvania.; Hong H; Bioimaging (S.C.L., T.S., M.R., S.-H.C., H.H., B.M.J.), Renal Discovery Group, Future Pipeline Discovery (A.V, E.H.), Experimental Cell and Tissue Biology, Target and Pathway Validation (W.F., H.T., R.G., J.-L.K.), Drug Delivery (A.M., D.L.), and Drug Design and Selection (A.I.-L., A.N.), GlaxoSmithKline plc, Collegeville, Pennsylvania.; Isidro-Llobet A; Bioimaging (S.C.L., T.S., M.R., S.-H.C., H.H., B.M.J.), Renal Discovery Group, Future Pipeline Discovery (A.V, E.H.), Experimental Cell and Tissue Biology, Target and Pathway Validation (W.F., H.T., R.G., J.-L.K.), Drug Delivery (A.M., D.L.), and Drug Design and Selection (A.I.-L., A.N.), GlaxoSmithKline plc, Collegeville, Pennsylvania.; Nadin A; Bioimaging (S.C.L., T.S., M.R., S.-H.C., H.H., B.M.J.), Renal Discovery Group, Future Pipeline Discovery (A.V, E.H.), Experimental Cell and Tissue Biology, Target and Pathway Validation (W.F., H.T., R.G., J.-L.K.), Drug Delivery (A.M., D.L.), and Drug Design and Selection (A.I.-L., A.N.), GlaxoSmithKline plc, Collegeville, Pennsylvania.; Geske R; Bioimaging (S.C.L., T.S., M.R., S.-H.C., H.H., B.M.J.), Renal Discovery Group, Future Pipeline Discovery (A.V, E.H.), Experimental Cell and Tissue Biology, Target and Pathway Validation (W.F., H.T., R.G., J.-L.K.), Drug Delivery (A.M., D.L.), and Drug Design and Selection (A.I.-L., A.N.), GlaxoSmithKline plc, Collegeville, Pennsylvania.; Klein JL; Bioimaging (S.C.L., T.S., M.R., S.-H.C., H.H., B.M.J.), Renal Discovery Group, Future Pipeline Discovery (A.V, E.H.), Experimental Cell and Tissue Biology, Target and Pathway Validation (W.F., H.T., R.G., J.-L.K.), Drug Delivery (A.M., D.L.), and Drug Design and Selection (A.I.-L., A.N.), GlaxoSmithKline plc, Collegeville, Pennsylvania.; Lee D; Bioimaging (S.C.L., T.S., M.R., S.-H.C., H.H., B.M.J.), Renal Discovery Group, Future Pipeline Discovery (A.V, E.H.), Experimental Cell and Tissue Biology, Target and Pathway Validation (W.F., H.T., R.G., J.-L.K.), Drug Delivery (A.M., D.L.), and Drug Design and Selection (A.I.-L., A.N.), GlaxoSmithKline plc, Collegeville, Pennsylvania.; Jucker BM; Bioimaging (S.C.L., T.S., M.R., S.-H.C., H.H., B.M.J.), Renal Discovery Group, Future Pipeline Discovery (A.V, E.H.), Experimental Cell and Tissue Biology, Target and Pathway Validation (W.F., H.T., R.G., J.-L.K.), Drug Delivery (A.M., D.L.), and Drug Design and Selection (A.I.-L., A.N.), GlaxoSmithKline plc, Collegeville, Pennsylvania.; Hu E; Bioimaging (S.C.L., T.S., M.R., S.-H.C., H.H., B.M.J.), Renal Discovery Group, Future Pipeline Discovery (A.V, E.H.), Experimental Cell and Tissue Biology, Target and Pathway Validation (W.F., H.T., R.G., J.-L.K.), Drug Delivery (A.M., D.L.), and Drug Design and Selection (A.I.-L., A.N.), GlaxoSmithKline plc, Collegeville, Pennsylvania Erding.Hu@gsk.com.

Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0376362 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0103 (Electronic) Linking ISSN: 00223565 NLM ISO Abbreviation: J Pharmacol Exp Ther Subsets: MEDLINE

Blackwell C; Oncology R&D, GlaxoSmithKline Research and Development, Collegeville, PA 19426, USA.; Sherk C; Oncology R&D, GlaxoSmithKline Research and Development, Collegeville, PA 19426, USA.; Fricko M; Oncology R&D, GlaxoSmithKline Research and Development, Collegeville, PA 19426, USA.; Ganji G; Oncology R&D, GlaxoSmithKline Research and Development, Collegeville, PA 19426, USA.; Barnette M; Oncology R&D, GlaxoSmithKline Research and Development, Collegeville, PA 19426, USA.; Hoang B; Platform Technology and Science, GlaxoSmithKline Research and Development, King of Prussia, PA 19406, USA.; Tunstead J; Platform Technology and Science, GlaxoSmithKline Research and Development, King of Prussia, PA 19406, USA.; Skedzielewski T; Platform Technology and Science, GlaxoSmithKline Research and Development, King of Prussia, PA 19406, USA.; Alsaid H; Platform Technology and Science, GlaxoSmithKline Research and Development, King of Prussia, PA 19406, USA.; Jucker BM; Platform Technology and Science, GlaxoSmithKline Research and Development, King of Prussia, PA 19406, USA.; Minthorn E; Oncology R&D, GlaxoSmithKline Research and Development, Collegeville, PA 19426, USA.; Kumar R; Oncology R&D, GlaxoSmithKline Research and Development, Collegeville, PA 19426, USA.; DeYoung MP; Oncology R&D, GlaxoSmithKline Research and Development, Collegeville, PA 19426, USA.

Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE

Linder KE; Ernst Felder Laboratories, Bracco Research USA, 305 College Road East, Princeton, New Jersey 08540, United States. karen.e.linder@gmail.com; Metcalfe E; Nanjappan P; Arunachalam T; Ramos K; Skedzielewski TM; Marinelli ER; Tweedle MF; Nunn AD; Swenson RE

Publisher: American Chemical Society Country of Publication: United States NLM ID: 9010319 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4812 (Electronic) Linking ISSN: 10431802 NLM ISO Abbreviation: Bioconjug Chem Subsets: MEDLINE

Cagnolini, A.; Chen, J.; Ramos, K.; Marie Skedzielewski, T.; Lantry, L.E.; Nunn, A.D.; Swenson, R.E.; Linder, K.E.

In: Applied Radiation and Isotopes. (Applied Radiation and Isotopes, December 2010, 68(12):2285-2292)

Solomon, H. M.; Murzyn, S.; Skedzielewski, T.; Rendemonti, J.; Chapman, S.; Alsaid, H.

BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY; MAY 2016, 106 5, p424-p424, 1p.

Alsaid, Hasan; Cheng, Shih-Hsun; Bi, Meixia; Rambo, Mary V.; Skedzielewski, Tinamarie; Hoang, Bao; Mohanan, Sunish; Gehman, Andrew; Hsu, Chih-Yang; Doan, Minh; Xie, Fang; Groseclose, M. Reid; Hopson, Christopher; Brett, Sara; Wilson, Ian A.; Nicholls, Andrew; Ballas, Marc; Waight, Jeremy D.; Jucker, Beat M.; Hoos, Axel

CANCER RESEARCH; JUL 2021, 81 13, 2p. Supplement: S